Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study
<p><strong>Background:</strong> In the UK, 10% of admissions to intensive care units receive continuous renal replacement therapy with regional citrate anticoagulation replacing systemic heparin anticoagulation over the last decade. Regional citrate anticoagulation is now...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Report |
| Language: | English |
| Published: |
NIHR
2022
|